Browse EX-10 agreements

AT-THE-MARKET ISSUANCE SALES AGREEMENT

July 20, 2026

Aegis Capital Corp.

1345 Avenue of the Americas, 27th Floor
New York, NY 10105

Ladies and Gentlemen:

Sunshine Biopharma Inc., a Colorado corporation (the “Company”), confirms its agreement (this “Agreement”) with Aegis Capital Corp. (“Sales Agent”), as follows:

| | |

…

[Dealer name and address]

** **

To:	AST SpaceMobile, Inc. Midland International Air & Space Port 2901 Enterprise Lane Midland, Texas 79706
From:	[Dealer]
Re:	Base Capped Call Transaction

…

Exhibit 10.4English Convenience TranslationOriginal agreement has been executed in ChineseD-02: Working Capital Loan Contract - Applicable to Single, Class A, and Class B Single Working Capital Loan Business

Working Capital Loan Contract

No.:150176529D260713001

Borrower: Gemstar Technology (Yangzhou) Co. Ltd.

Unified Social Credit Code: 91321023769142817E

Legal Representative/Person in Charge: SZETO , CHI KONG

…

Exhibit 10.1English Convenience TranslationOriginal agreement has been executed in ChineseA-01: Line of Credit Agreement - -Applicable to Line of Credit Business

Line of Credit Agreement

No. 150176529E260713001

Party A: Gemstar Technology (Yangzhou) Co. Ltd.

Unified Social Credit Code: 91321023769142817E

Legal Representative/Person in Charge:SZETO , CHI KONG

Domicile:No. 9, Junsheng Road, Concentrated Industrial Zone, Fanshui Town, Baoying County, Zip Code:225800

…

**SEPARATION AGREEMENT **

This Separation Agreement (the “Agreement”) is entered into by and between NEURONETICS, INC., a Delaware corporation, and W. ANDREW MACAN (“Executive”) (together, “*the *Parties”) to set forth their mutual agreement to resolve and discharge any claims and obligations arising in connection with Executive’s employment or separation from service.

*RECITALS *

WHEREAS, Executive has been employed as an officer of the Company since on or about January 21, 2020, including, most recently, in the position of Executive Vice President, Chief Legal Officer, and Secretary;

WHEREAS, the Parties entered into various agreements over the course of Executive’s service with the Company, including a Restrictive Covenant and Severance Agreement dated July 1, 2021 (“the RCSA”) and a Restrictive Covenant and Invention Assignment Agreement (“RCIAA”), both of which currently remain in force;

…

July 10, 2026

VIA EMAIL

Nir Naor

Atlanta, GA 30068 Email:

Dear Nir:

On behalf of everyone at Neuronetics, I am delighted at the prospect of you joining the team as Chief Financial Officer & Treasurer. Your employment offer with Neuronetics, Inc. will be on the following terms:

| | | |

…

Execution Version

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (i) NOT MATERIAL AND (ii) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.

ASSET PURCHASE AGREEMENT

BY AND BETWEEN

CELLUTION BIOLOGICS INC.

AND

ELUTIA INC.

July 16, 2026

TABLE OF CONTENTS

…

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

This First Amendment (“Amendment”) to that certain Employment Agreement, effective June 23, 2025 (the “Agreement”), by and between Asim Akram (the “Executive”) and MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”), shall be effective as of the date it is fully executed by the parties hereto (the “Effective Date”). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings ascribed to them in the Agreement.

WHEREAS, the Company and the Executive desire to amend the Agreement to provide for accelerated vesting of the Executive’s outstanding equity awards in the event of a Change in Control of the Company.

NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein and in the Agreement, the parties hereto agree as follows:

1. Amendment to Equity Award Treatment. Section 3(c) of the Agreement is hereby amended by adding the following new subsections at the end thereof:

…

SECOND AMENDMENT TO

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

​

This Second Amendment (“Amendment”) to that certain Amended and Restated Employment Agreement, effective February 5, 2025 (the “Agreement”), by and between Robert Nadolny (the “Executive”) and MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”), shall be effective as of the date it is fully executed by the parties hereto (the “Effective Date”). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings ascribed to them in the Agreement.

WHEREAS the Company and the Executive desire to amend the Agreement to provide for accelerated vesting of the Executive’s outstanding equity awards in the event of a Change in Control of the Company.

NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein and in the Agreement, the parties hereto agree as follows:

1. Amendment to Equity Award Treatment. Section 3(f) of the Agreement is hereby amended by adding the following new subsection at the end thereof:

…

​

Exhibit 10.2

​

MULTISENSOR AI HOLDINGS, INC.

**​
**2023 INCENTIVE AWARD PLAN

​

Performance STOCK Unit Grant Notice

MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”), has granted to the participant listed below (“Participant”) the Performance Stock Units (the “PSUs”) described in this Performance Stock Unit Grant Notice (this “Grant Notice”), subject to the terms and conditions of the MultiSensor AI Holdings, Inc. 2023 Incentive Award Plan (as amended from time to time, the “Plan”) and the Performance Stock Unit Agreement attached hereto as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference. Capitalized terms not specifically defined in this Grant Notice or the Agreement have the meanings given to them in the Plan.

| |

​

Exhibit 10.1

​

MULTISENSOR AI HOLDINGS, INC.

**​
**2023 INCENTIVE AWARD PLAN

​

RESTRICTED STOCK Unit Grant Notice

MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”), has granted to the participant listed below (“Participant”) the Restricted Stock Units (the “RSUs”) described in this Restricted Stock Unit Grant Notice (this “Grant Notice”), subject to the terms and conditions of the MultiSensor AI Holdings, Inc. 2023 Incentive Award Plan (as amended from time to time, the “Plan”) and the Restricted Stock Unit Agreement attached hereto as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference. Capitalized terms not specifically defined in this Grant Notice or the Agreement have the meanings given to them in the Plan.

| |

AMENDMENT NO. 2 TO PURCHASE AGREEMENT

This AMENDMENT NO. 2 TO PURCHASE AGREEMENT (this “Second Amendment”), dated as of July 16, 2026, is made and entered into by and between Marpai, Inc., a New York corporation (“Marpai”) and AXA S.A., a French société anonyme (“AXA”). Marpai and AXA are sometimes referred to herein collectively as the “Parties.” Unless otherwise indicated, capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Amended Purchase Agreement (defined below).

R E C I T A L S

…